Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii

被引:13
|
作者
Lomovskaya, Olga [1 ,4 ]
Sun, Dongxu [1 ]
Rubio-Aparicio, Debora [1 ]
Nelson, Kirk J. [1 ]
Thamlikitkul, Visanu [2 ]
Dudley, Michael N. [1 ]
Redell, Mark A. [3 ]
机构
[1] The Med Co, 3013 Sci Pk Rd, San Diego, CA 92121 USA
[2] Mahidol Univ, Siriraj Hosp, Dept Med, Div Infect Dis & Trop Med,Fac Med, Bangkok 10700, Thailand
[3] Melinta Therapeut, 300 George St, New Haven, CT 06511 USA
[4] The Med Co, Infect Dis, Biol, 3013 Sci Pk Rd,1st Floor, San Diego, CA 92121 USA
关键词
Minocycline; Acinetobacter; Efflux; TetB; Tetracycline; Resistance; EFFLUX; RESISTANCE; COMPLEX; UPDATE; GENES;
D O I
10.1016/j.ijantimicag.2018.04.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Minocycline is one of the few options available to treat infections caused by Acinetobacter baumannii. Acquired resistance to minocycline in A. baumannii is associated with presence of the TetB efflux pump. Previous studies suggested that the absence of tetB may predict minocycline minimum inhibitory concentrations (MICs) of <= 4 mu g/mL. In this study, a collection of 258 A. baumannii isolates was used to generate MIC frequency distributions for the tetB-positive and -negative sets of isolates. Of the 93 tetB -negative strains, all had minocycline MICs <= 4 mu g/mL, resulting in a negative predictive value of 100%. Of the 165 tetB-positive strains, 154 had minocycline MICs > 4 mu g/mL, resulting in a positive predictive value of 93.3%. In conclusion, this study shows that tetB is highly associated with MICs above the current US Food and Drug Administration (FDA) and Clinical and Laboratory Standards Institute (CLSI) susceptible breakpoint of 4 mu g/mL. (c) 2018 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:404 / 406
页数:3
相关论文
共 50 条
  • [41] Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii
    Wang, Peng
    Bowler, Sarah L.
    Kantz, Serena F.
    Mettus, Roberta T.
    Guo, Yan
    McElheny, Christi L.
    Doi, Yohei
    JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (12) : 2937 - 2941
  • [42] Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model
    Zhou, Jian
    Ledesma, Kimberly R.
    Chang, Kai-Tai
    Abodakpi, Henrietta
    Gao, Song
    Tam, Vincent H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (05)
  • [43] Minocycline: An Old Drug for a New Bug: Multidrug-Resistant Acinetobacter baumannii
    Goff, Debra A.
    Kaye, Keith S.
    CLINICAL INFECTIOUS DISEASES, 2014, 59 : S365 - S366
  • [44] Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan
    Endo, Shiro
    Yano, Hisakazu
    Hirakata, Yoichi
    Arai, Kazuaki
    Kanamori, Hajime
    Ogawa, Miho
    Shimojima, Masahiro
    Ishibashi, Noriomi
    Aoyagi, Tetsuji
    Hatta, Masumitsu
    Yamada, Mitsuhiro
    Tokuda, Koichi
    Kitagawa, Miho
    Kunishima, Hiroyuki
    Kaku, Mitsuo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (07) : 1623 - 1626
  • [45] Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii
    Jo, J. W.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 : 56 - 56
  • [46] Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii
    King, Lauren B.
    Swiatlo, Edwin
    Swiatlo, Andrea
    McDaniel, Larry S.
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2009, 55 (03): : 414 - 421
  • [47] In vitro activity of ceftobiprole against Acinetobacter baumannii clinical isolates
    Marti, Sara
    Sanchez-Cespedes, Javier
    Espinal, Paula
    Vila, Jordi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (03) : 265 - 267
  • [48] Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes
    Altun, Hatice Uludag
    Yagci, Server
    Bulut, Cemal
    Sahin, Hunkar
    Kinikli, Sami
    Adiloglu, Ali Kudret
    Demiroz, Ali Pekcan
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (12)
  • [49] Acinetobacter baumannii outbreak isolates characterized by three typing methods
    Aubert, G
    Grimont, F
    Zeni, F
    Pain, P
    Michel, VP
    Vautrin, AC
    Vedel, G
    Bouvet, P
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (12) : 1095 - 1099
  • [50] Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii
    Jo, J. W.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (41) : 56 - 56